We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/1/2021 16:10 | You try to confuse,Reb, hoping others have not done there research. | impala391 | |
22/1/2021 16:04 | Very nice buddy, such enlightenment you provide! | rebelwithacause1 | |
22/1/2021 16:03 | Back on FILTER then | yidarmytom | |
22/1/2021 16:02 | I'm not going to answer that buddy, take some time to read over the comments, it will soon become clear! | rebelwithacause1 | |
22/1/2021 16:01 | Shish, WHAT IS THE QUESTION FFS? | yidarmytom | |
22/1/2021 16:00 | Is Tils becoming clear now to the masses as Tom has so kindly provided such great information! Absolutely nothing is guaranteed here... | rebelwithacause1 | |
22/1/2021 16:00 | Temp removal of the filter only for Reb, not the other Morons I mentioned, WHAT IS THE QUESTION FSS? | yidarmytom | |
22/1/2021 15:58 | hxxps://clinicaltria Milciclib for HCC Phase 2, 70 patients, again we need big expansion here to get this thing really moving | yidarmytom | |
22/1/2021 15:57 | Well thanks for that Tom, I'm grateful, you simpleton! I would like you to answer my burning question, its on the first page of this board - can you try at least! | rebelwithacause1 | |
22/1/2021 15:54 | The Company really does need to get a move on with trials now, given Phase 2's usually take 3 years!! Only 40 participants for Crohns so they need a massive expansion here and that needs pursuing pronto! hehe! hxxps://clinicaltria | yidarmytom | |
22/1/2021 15:52 | I can provide the FDA data and trial information if Rebs needs it | yidarmytom | |
22/1/2021 15:51 | absolutely agree Impala, If Rebs is spouting his usual mis-information get him to look at the website it is in Phase 2 for Crohns and starting P2 this year for other indications | yidarmytom | |
22/1/2021 15:48 | It is at preliminary stages that have assumed safety adequacy nothing else...And it is very small cohort to realise with any degree of real confidence that it works. In no way does it guarantee future success...it has to be 'Inch Perfect'! | rebelwithacause1 | |
22/1/2021 15:46 | Foralumab isnt pre clinical ,it’s been taken by loads ,from original trial with Novimmune,the creators,and demonstrated efficacy. | impala391 | |
22/1/2021 15:43 | It just begs the question- Would anyone provide an 'Actual' address to another poster they have never seen? So now you see why the dear fool Mark0419 is actually more incompetent than we actually thought - oops! ...And YidTom I'll ask again - How many pre-clinical trials have demonstrated safety adequacy and then faltered in further trials? It should be right up your street considering how much relevant experience you have or think you have buddy! | rebelwithacause1 | |
22/1/2021 15:40 | Dr. Shailubhai CEO/CSO on #Milciclib #OrphanDrug data in patients with Hepatocellular carcinoma (HCC) and Nonsmall-cell lung carcinoma (NSCLC): “I can tell you comfortably, Milciclib mono-therapy is outperforming existing mono-therapies” | yidarmytom | |
22/1/2021 15:35 | That feels better filtered. | mark0419 | |
22/1/2021 15:34 | MarkyBoy U lostThe tool don’t bea jealousCnt CNT | andymunchkin | |
22/1/2021 15:31 | Filter them all IMO Mark, then we ca get back to properly discussing Tiziana next week, something none of them are remotely capable of doing. | yidarmytom | |
22/1/2021 15:30 | reb still asking the question but never actually asking the question hehe!! | yidarmytom | |
22/1/2021 15:29 | Is it the age that doesn't allow you to adapt or just ignorance my dear friend! | rebelwithacause1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions